Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2012-10-25 Capital/Financing Update
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Expiry of options 1 page 34.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated October 26, 2012, regarding the cancellation of options previously issued to former employees. It provides specific details about the number of options, exercise prices, and expiry dates. The content is a brief corporate announcement about capital structure changes related to options forfeiture and expiry. It does not contain financial statements, management discussion, or detailed financial data. It is not a report or a regulatory filing about financial results or governance changes. The nature of the announcement fits best under Capital/Financing Update (CAP), as it relates to changes in the company's capital instruments (options). The document length is short and focused solely on this update, confirming it is not a full report or other category.
2012-10-25 English
US Annual Report on Form 20-F - 30 June 2012 178 pages 1.5MB
Annual Report Classification · 100% confidence The document is titled 'US Annual Report on Form 20-F' and references the fiscal year ended June 30, 2012. It is filed with the US Securities and Exchange Commission (SEC) and contains detailed sections typical of an annual report, including financial statements, management discussion, risk factors, and corporate governance. The length of the document (15,000 characters) and the presence of comprehensive content indicate it is the full annual report itself, not just an announcement or a certification. The Form 20-F is the SEC's annual report form for foreign private issuers, equivalent to the 10-K for US companies. Therefore, the document fits the definition of an Annual Report (10-K equivalent). FY 2012
2012-10-24 English
Appendix 4C - quarterly 10 pages 53.0KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 September 2012.' It contains detailed operational updates, financial summaries, licensing activities, corporate matters, and an Appendix 4C which is a quarterly cash flow report. The content includes substantive financial data and analysis for a quarter, consistent with a comprehensive interim or quarterly report. It is not merely an announcement or a brief summary, nor is it a full annual report or earnings release. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2013
2012-10-24 English
Issue of shares, cleansing notice and Appendix 3B 12 pages 117.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated October 19, 2012, concerning a cleansing notice under section 708A of the Corporations Act 2001 (Cth). It details the exercise of 10,200,000 options over the company's ordinary shares and includes an Appendix 3B, which is a standard form used in Australian securities markets for new issue announcements and applications for quotation of additional securities. The content focuses on the issuance of shares following option exercises, compliance with relevant sections of the Corporations Act, and details about the securities issued. There are no financial statements, management discussion, or earnings data presented. The document is regulatory in nature, announcing a capital issuance event and compliance with disclosure requirements, but it is not a full financial report or earnings release. Given the detailed nature of the announcement and the inclusion of the Appendix 3B form, this fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2012-10-18 English
Genetic Technologies executes agreement with One Lambda Inc. 1
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated October 18, 2012, reporting that Genetic Technologies Limited has executed a Covenant Not To Sue And Release Agreement with One Lambda Inc. It is a brief announcement about a legal agreement related to patent monetization efforts. The document does not contain financial statements, detailed financial data, or management discussion. It is not a full report like an Annual Report or Interim Report, nor is it a call transcript or investor presentation. It is also not a regulatory certification or officer attestation. The content is a regulatory announcement about a legal agreement, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories. The document length is 4088 characters, which is short and typical for an announcement rather than a full report.
2012-10-17 English
2012 Notice of AGM, Proxy and Annual Report 115 pages 6.2MB
AGM Information Classification · 95% confidence The document is an ASX announcement dated October 18, 2012, regarding the Notice of Annual General Meeting (AGM), a Sample Proxy, and the 2012 Annual Report of Genetic Technologies Limited. It includes detailed information about the AGM date, location, agenda items such as election and re-election of directors, adoption of the remuneration report, and approval of additional placement capacity. The document also contains proxy voting instructions and an explanatory memorandum supporting the resolutions. The text explicitly states it is a Notice of Annual General Meeting and includes proxy materials and explanatory notes for shareholders. Although it references the 2012 Annual Report, the report itself is not included but is available for download on the company's website. The document is comprehensive and primarily serves as the official Notice of AGM and proxy solicitation materials rather than the Annual Report itself. Therefore, the most appropriate classification is AGM Information (AGM-R).
2012-10-17 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.